Transformation of Accessible Chromatin and 3D Nucleome Underlies Lineage Commitment of Early T Cells
Abstract
How chromatin reorganization coordinates differentiation and lineage commitment from hematopoietic stem and progenitor cells (HSPCs) to mature immune cells has not been well understood. Here, we carried out an integrative analysis of chromatin accessibility, topologically associating domains, AB compartments, and gene expression from HSPCs to CD4+CD8+ T cells. We found that abrupt genome-wide changes at all three levels of chromatin organization occur during the transition from double-negative stage 2 (DN2) to DN3, accompanying the T lineage commitment. The transcription factor BCL11B, a critical regulator of T cell commitment, is associated with increased chromatin interaction, and Bcl11b deletion compromised chromatin interaction at its target genes. We propose that these large-scale and concerted changes in chromatin organization present an energy barrier to prevent the cell from reversing its fate to earlier stages or redirecting to alternatives and thus lock the cell fate into the T lineages.
Additional Information
© 2018 Elsevier Inc. Received 25 September 2017, Revised 5 December 2017, Accepted 26 January 2018, Available online 20 February 2018. We thank the National Heart, Lung, and Blood Institute (NHLBI) DNA Sequencing and Genomics Core facility for sequencing, the NHLBI Systems Biology Center and the NIH Biowulf High Performance Computing systems for computing service, the NHLBI Flow Cytometry Core facility for cell sorting, Dr. X. Zheng and Dr. B. Stanton for constructive comments, Dr. D. Northrup for assistance with cell sorting, Dr. G. Ren and Dr. K. Placek for assistance with cell isolation, Dr. H. Shin and Prof. X.J. Zhou (University of California, Los Angeles) for sharing the code of TopDOM, Mr. Timothy Zhou for setting up a local WashU genome browser, and Dr. D. Li and Prof. T. Wang (Washington University in St. Louis) for hosting the online WashU Epigenome Browser session. The work was supported by the Division of Intramural Research of the National Cancer Institute (T.R.), National Institute of Allergy and Infectious Diseases (J.Z.), and NHLBI (K.Z.) and NIH grant R01 AI083514 (E.V.R.). Author Contributions: G.H., E.V.R., and K.Z. designed the project and wrote the manuscript. K.C., S.H., and X.W. performed Hi-C and DNase, RNA, and ChIP sequencing experiments. G.H. and W.J. performed computational analysis. D.W. performed the DNA fluorescence in situ hybridization experiment. D.F. performed the Bcl11b deletion. T.R., P.L., and J.Z. contributed to data interpretation and manuscript editing. The authors declare no competing interests.Attached Files
Accepted Version - nihms944323.pdf
Supplemental Material - mmc1.pdf
Supplemental Material - mmc2.xlsx
Supplemental Material - mmc3.xlsx
Supplemental Material - mmc4.xlsx
Supplemental Material - mmc5.xlsx
Supplemental Material - mmc6.xlsx
Supplemental Material - mmc7.xlsx
Supplemental Material - mmc8.xlsx
Files
Name | Size | Download all |
---|---|---|
md5:f84d467197731d3a7800f39f45a78213
|
10.6 kB | Download |
md5:de31c4bec8019d8a256bad9bb7afc54d
|
3.7 MB | Preview Download |
md5:c9728ef32ce0ddffb2c505671d50332f
|
13.3 kB | Download |
md5:fa36df832c8a4b407aa9b6027aec51fa
|
544.0 kB | Download |
md5:71c2b1a6e70aa13ab06e945d61ff1161
|
50.4 kB | Download |
md5:112dc1f2434099522a1c3e1e383de066
|
143.9 kB | Download |
md5:7ac61b84f3d4cf61bc3ac9b4abc9128c
|
1.8 MB | Preview Download |
md5:4bb46db94ae45261a54d06ebfdae7e46
|
1.9 MB | Download |
md5:efdb61598cda2c7332d51ef8ca4c690a
|
17.0 kB | Download |
Additional details
- PMCID
- PMC5847274
- Eprint ID
- 84933
- DOI
- 10.1016/j.immuni.2018.01.013
- Resolver ID
- CaltechAUTHORS:20180223-094424466
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
- NIH
- R01 AI083514
- Created
-
2018-02-23Created from EPrint's datestamp field
- Updated
-
2022-03-17Created from EPrint's last_modified field